This Ridiculously Cheap Growth Stock Could Make You a Millionaire

Why It Matters

Hormel’s low valuation combined with consistent dividend growth and improving margins offers a rare, long‑term wealth‑building opportunity in the defensive consumer‑staples sector. Its strategic focus on branded, high‑margin proteins positions the company for sustainable earnings expansion.

Key Takeaways

• Hormel shares down ~47% over five years, near $20 price.
• Five straight quarters of organic net‑sales growth, driven by foodservice.
• Sale of turkey business narrows focus to higher‑margin branded proteins.
• Dividend King status yields ~4% and 60‑year dividend growth streak.
• Projected 5‑7% operating‑profit growth could push valuation to historic levels.

Pulse Analysis

Hormel Foods’ current share price reflects a deep discount that many investors overlook. The 47% decline over five years has pushed the stock to roughly $20, a level not seen since the early 2010s when the company’s price‑to‑earnings multiple hovered near historic averages. In a market where consumer‑staple stocks often trade at premium multiples due to their defensive nature, Hormel’s valuation gap creates a compelling entry point for long‑term investors seeking both capital appreciation and income.

The growth narrative for Hormel is now anchored in its foodservice and international segments, which have delivered high single‑digit organic growth for five straight quarters. By exiting the whole‑bird turkey business and trimming low‑margin private‑label snacks, Hormel is sharpening its portfolio toward branded, value‑added protein products such as Spam, Skippy and Justin’s. These brands enjoy strong consumer loyalty and higher pricing power, especially in foodservice channels that typically generate superior margins compared with retail. The strategic divestitures also reduce exposure to volatile commodity costs, positioning the company for steadier earnings.

Beyond price and growth, Hormel’s 60‑year streak of dividend increases places it among an elite group of Dividend Kings, offering a current yield near 4%. For investors who can commit $500 monthly, the combination of dividend reinvestment and the company’s target 5‑7% operating‑profit growth can compound to a seven‑figure portfolio within three decades. While commodity inflation and retail softness remain risks, Hormel’s disciplined focus on high‑margin branded proteins and its robust dividend track record make it a standout long‑term play in the consumer‑staples arena.